DIANABOL INJECTABLE

DIANABOL INJECTABLE is introduced in vial and apparently contains 100 milligrams of methenolone enanthate per milliliter as indicated by name and additionally bundling. Tests of this item were bought from an European-based web source between the dates of August 1, 2016 and September 15, 2016.1′

The examples were sent and gotten by the explanatory lab SIMEC AG on September 29, 2016. SIMEC performed HPLC-UV quantitative measurement testing, ‘all out aerobial microbiological check’ (TAMC) testing and ‘absolute yeast and shape tally’ (TYMC) testing. The report was finished on November 17, 2016.

The “part number” recorded on the item was GP138CN and the lapse date was March 2018. The ISN number “A4N6814M92DP” was effectively used to confirm the validness of the item on genezapharmaceuticals.com.

Mark guarantee: Geneza Pharmaceuticals GP Prima 100 has a name guarantee of 100 mg/ml methenolone enanthate.

Real substance: Geneza Pharmaceuticals GP Prima 100 was resolved to have a real substance of 96.4 mg/ml methenolone enanthate.